生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Roblitinib, also known as FGF-401, is an orally active, highly selective inhibitor of FGFR4, with an IC50 of 1.9 nM. Roblitinib shows no activity against FGFR1, FGFR2, FGFR3, rat FGFR4, and C552A FGFR4 (all IC50s >10 µM). It inhibits HUH7 (IC50=12 nM), Hep3B (IC50=9 nM), JHH7 (IC50=9 nM), while showing no inhibitory activity in HEPG2 and JHH (both IC50s >10 µM)[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.97mL 0.39mL 0.20mL |
9.87mL 1.97mL 0.99mL |
19.74mL 3.95mL 1.97mL |
参考文献 |
---|